AKRO

Akero Therapeutics $54.65 1M +1.1% 3M +26.4% YTD +94.6% as of 2025-12-09
Watchlist
This price data has stopped updating. The last bar is 2025-12-09, 279 days ago — our data source no longer publishes AKRO. Everything below is as of that date, not today.

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.0%
Next 1 week
+0.5%
Next 1 month
-0.1%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 70
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.07%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.56 -0.1% · Seasonal tilt (6y) -0.0%
$125M/day volume 112% volatility +84% 1-year -6% from ATH
52-week range · 90% of the way up · -6% from the high
$21.34$58.40

Congressional trades in AKRO Full tracker →

1 member · 1 buys / 0 sells · $1K–$15K disclosed · latest filing Dec 12, 2022.

BUY CJ Christopher L. Jacobs · traded Nov 8, 2022 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.